Fact CheckerSign in

NCT06112327Enrolling by invitation

Long-term Follow-up of Participants Dosed With an Investigational Gene Editing Therapy for Cardiovascular Disease

Long-term Follow-up Study of Investigational Gene-editing Therapies in Participants With or at High Risk for Cardiovascular Disease

Source: ClinicalTrials.gov · Last updated 8 Apr 2026

Brief summary (registry, in English)

LTF-001 is a long-term follow-up study of participants who received an investigational gene-editing therapy developed by the sponsor to evaluate the long-term effects of the investigational therapy. Participants will be followed for a total of 15 years after the first administration of the gene-editing therapy.

Status (registry)
Enrolling by invitation
Study type
Observational
Enrollment
116 (estimated)
First submitted
12 Oct 2023
Start date
9 Jun 2024
Primary completion date
Oct 2039
Lead sponsor
Verve Therapeutics, Inc.
NCT number
NCT06112327

What you commit to

  • Study type: Observational
  • Planned participants: 116
  • From 9 Jun 2024 to the primary completion date, Oct 2039
  • 3 sites in 2 countries
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Who the study is looking for

  • A participant has completed or discontinued from a Verve sponsored clinical study in which they received at least one dose of study drug.
  • A participant has provided informed consent for LTF-001.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (3)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Clinical Study Center
Coordinator of this site? Confirm its status
LondonUnited KingdomUnknown status
Clinical Study Center
Coordinator of this site? Confirm its status
AucklandNew ZealandUnknown status
Clinical Study Center
Coordinator of this site? Confirm its status
ChristchurchNew ZealandUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.